Skip to main content

Table 1 Risk stratification by clinical risk factors: Clinical T-stage, Gleason score, and presenting PSA. Locally advance prostate cancer includes high-risk localised patients, as defined by NCCN [16]

From: Joint models for dynamic prediction in localised prostate cancer: a literature review

Risk level Clinical T-stage Gleason Grading Group Presenting PSA Condition to be met
Low risk T1-T2a 1 <  10 ng/mL All three
Intermediate risk T2b-c 2 or 3 10-20 ng/mL Any
High risk T3a 4 or 5 > 20 ng/mL Any